Supplements and Featured Publications
Role of Trop-2 as an Actionable Biomarker in Solid Tumors
Volume: 1
Issue: 1
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer
Volume: 1
Issue: 1
ESMO 2020 Congress: Focus in Genitourinary Cancers
Volume: 1
Issue: 1
Updates and New Targets in NSCLC: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
2020 EBMT Meeting Reporter
Volume: 1
Issue: 1
Considerations for the Management of Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers
Volume: 1
Issue: 1
Year in Review: Updates in DLBCL Treatment
Volume: 1
Issue: 1
Updates in Relapsed/Refractory Metastatic Renal Cell Carcinoma: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
Current and Emerging Treatments in Follicular Lymphoma
Volume: 1
Issue: 1
Antibody-Drug Conjugates in HER2+ Breast Cancer
Volume: 1
Issue: 1
New Developments in the Use of Immunotherapy for the Treatment of Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
Volume: 1
Issue: 1
2020 World GI: Updates in HER2+ GI Cancers
Volume: 1
Issue: 1
Exploring Therapeutic Strategies in Myelodysplastic Syndromes
Volume: 2020
Issue: 1
Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Volume: 1
Issue: 1
OncLive® provides updates on the treatment of patients with diffuse large B-cell lymphoma through a Scientific Exchange Workshop.
ASCO 2020: Update on Genitourinary Cancers
Volume: 1
Issue: 1
Advanced HER2-Expressing Breast Cancer: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
My Treatment Approach: HER2-Positive Breast Cancer
Volume: 1
Issue: 1
Year in Review: Evolving Landscape in Multiple Myeloma
Volume: 1
Issue: 1
Therapeutic Changes in HER2+ Breast Cancer
Volume: 1
Issue: 1
Emerging Advances in Gastrointestinal Cancers
Volume: 1
Issue: 1
2020 Genitourinary Cancers Symposium
Volume: 1
Issue: 1
Therapeutic Updates in Neuroendocrine Tumors
Volume: 1
Issue: 1
2019 ESMO Immuno-Oncology Congress
Volume: 1
Issue: 1
BTK Inhibitors in B-Cell Lymphomas
Volume: 1
Issue: 1
Recent Advances in HER2+ Breast Cancer
Volume: 1
Issue: 1
Targeted Advances in ALK+ NSCLC
Volume: 1
Issue: 1
Rapid Reporter®
Volume: 1
Issue: 1
Pulmonologists in Cancer Care
Volume: 1
Issue: 1
Milestones in Medicine: History & Evolving Role of Interferon in Myeloproliferative Neoplasms
Volume: 1
Issue: 1
Dermatologists in Cancer Care®
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5